HIS
PTGX icon

Harvest Investment Services’s Protagonist Therapeutics PTGX Stock Holding History

Harvest Investment Services’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,029
Closed -$720K – 365
2025
Q2 		$720K Sell
13,029
-2,882
-18% -$138K 0.16% 147
2025
Q1 		$769K Buy
+15,911
New +$667K 0.21% 115
2023
Q3 		– Sell
-44,113
Closed -$1.22M – 187
2023
Q2 		$1.22M Buy
+44,113
New +$1.1M 0.69% 48
2022
Q2 		– Sell
-13,362
Closed -$316K – 184
2022
Q1 		$316K Sell
13,362
-5,265
-28% -$148K 0.19% 148
2021
Q4 		$637K Sell
18,627
-2,280
-11% -$72.1K 0.27% 112
2021
Q3 		$370K Buy
+20,907
New +$891K 0.15% 187

Other funds holding PTGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Harvest Investment Services's PTGX Position: Q3 2025 in Review

Harvest Investment Services sold out of Protagonist Therapeutics (PTGX) in Q3 2025, closing a stake of 13,029 shares — an estimated $720K sold.

Harvest Investment Services first reported a position in PTGX in Q3 2021 and held it in 6 quarters. The position peaked at $1.22M in Q2 2023. 274 funds tracked by Wall St. Rank hold PTGX as of Q3 2025.

  • Harvest Investment Services reported no remaining Protagonist Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Harvest Investment Services sold 13,029 Protagonist Therapeutics shares in Q3 2025, an estimated $720K.
  • Harvest Investment Services first reported a position in Protagonist Therapeutics in Q3 2021 and held it in 6 quarters.
  • Harvest Investment Services's Protagonist Therapeutics position peaked at $1.22M in Q2 2023.
  • 274 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2025.

Based on Harvest Investment Services's 13F filing for Q3 2025, filed 17 Nov 2025.